NON-SEGMENTAL VITILIGO (NSV)
Clinical trials for NON-SEGMENTAL VITILIGO (NSV) explained in plain language.
Never miss a new study
Get alerted when new NON-SEGMENTAL VITILIGO (NSV) trials appear
Sign up with your email to follow new studies for NON-SEGMENTAL VITILIGO (NSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to restore skin color in vitiligo patients
Disease control Recruiting nowThis study tests an experimental drug called LY4005130 in 60 adults with non-segmental vitiligo, a condition that causes white patches on the skin. Participants will receive either the drug or a placebo through an IV over 24 weeks. The goal is to see if the drug can safely help b…
Matched conditions: NON-SEGMENTAL VITILIGO (NSV)
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
Massive global study reveals hidden toll of skin diseases
Knowledge-focused Recruiting nowThis study aims to understand how alopecia areata, vitiligo, and hidradenitis suppurativa affect the daily lives and well-being of teens and adults. Researchers will collect information from nearly 2,800 participants across multiple countries using questionnaires and skin assessm…
Matched conditions: NON-SEGMENTAL VITILIGO (NSV)
Sponsor: AbbVie • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC